As described above, the PACAP subfamily of receptors can activate diverse signaling pathways leading to their pleiotropic effects throughout the body and are attractive targets for inflammatory and immune diseases, and disorders in the nervous system. Here, ADCYAP1 is linked to immune system disorder.